Impact BioMedical Inc. IBO
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 35.00K | 39.00K | 32.00K | 25.00K | 7.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 35.00K | 39.00K | 32.00K | 25.00K | 7.00K |
| Cost of Revenue | 424.00K | 424.00K | 424.00K | 2.00K | 1.00K |
| Gross Profit | -389.00K | -385.00K | -392.00K | 23.00K | 6.00K |
| SG&A Expenses | 2.97M | 3.37M | 1.98M | 2.29M | 2.50M |
| Depreciation & Amortization | 1.14M | 1.15M | 1.15M | 1.14M | 1.13M |
| Other Operating Expenses | 315.00K | 368.00K | 416.00K | 457.00K | 393.00K |
| Total Operating Expenses | 5.13M | 5.59M | 4.30M | 4.01M | 4.17M |
| Operating Income | -5.10M | -5.55M | -4.27M | -3.99M | -4.17M |
| Income Before Tax | -1.80M | -15.46M | -14.45M | -44.21M | -38.49M |
| Income Tax Expenses | -2.58M | -2.58M | -2.58M | 33.00K | 33.00K |
| Earnings from Continuing Operations | 0.78 | -12.88 | -11.87 | -44.24 | -38.52 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 13.00K | 18.00K | 32.00K | 47.00K | 48.00K |
| Net Income | 789.00K | -12.86M | -11.84M | -44.19M | -38.47M |
| EBIT | -5.10M | -5.55M | -4.27M | -3.99M | -4.17M |
| EBITDA | -3.39M | -3.83M | -2.56M | -2.56M | -3.59M |
| EPS Basic | -1.13 | -15.91 | -16.97 | -47.43 | -41.25 |
| Normalized Basic EPS | -0.93 | -10.17 | -10.82 | -12.23 | -8.36 |
| EPS Diluted | -1.19 | -15.96 | -17.08 | -47.53 | -45.25 |
| Normalized Diluted EPS | -0.93 | -10.17 | -10.82 | -12.23 | -10.81 |
| Average Basic Shares Outstanding | 25.16M | 17.59M | 10.00M | 3.80M | 3.75M |
| Average Diluted Shares Outstanding | 25.16M | 17.59M | 10.00M | 3.80M | 8.54M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |